Please select the outcome measures that correspond to the clinical trial below.
Title: Low Energy Density Diet and Weight Loss Maintenance
Brief Summary: Investigators presumed that low energy density (LED) diet consumers will have lower risk of cardiovascular disease and are able to maintain their weight longer .


Options:
A: better weight maintenance by LED (7 months)
B: Insulin Sensitivity (HOMA-IR) (4 weeks (from Baseline to 4 weeks)); Insulin Sensitivity (QUICKI) (4 weeks (from Baseline to 4 weeks)); Insulin Sensitivity (ISI-Index) (4 weeks (from Baseline to 4 weeks)); Insulin Sensitivity (Matsuda-Index) (4 weeks (from Baseline to 4 weeks))
C: Change From Baseline in Participant Glucose When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Human Growth Hormone (HGH) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Insulin When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Glycogen-Like Protein-1 (GLP-1) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Adiponectin When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Fibroblast Growth Factor-21 (FGF-21) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant White Blood Cell Count (WBC) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Hemoglobin When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Red Blood Cell Count (RBC) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Hematocrit When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Platelet Count When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Mean Corpuscular Volume (MCV) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Mean Corpuscular Hemoglobin (MCH) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Mean Corpuscular Hemoglobin Concentration (MCHC) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Red Cell Distribution Width (RDW) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Mean Platelet Volume (MPV) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Bicarbonate When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Sodium When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Chloride When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Blood Urea Nitrogen (BUN) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Calcium When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Potassium When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Creatinine When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Total Cholesterol (TC) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Low-Density Lipoprotein Cholesterol (LDL-C) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant High-Density Lipoprotein Cholesterol (HDL-C) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Triglycerides When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant TC/HDL Ratio When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Weight When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Waist Circumference When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Systolic Blood Pressure (SBP), Supine When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Diastolic Blood Pressure (DBP), Supine When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant High Sensitivity C-Reactive Protein (hsCRP) When Fasting and Fed (Baseline and 3 days)
D: Changes in gene expression in subcutaneous adipose tissue measured by whole genome sequencing (Assessments at baseline (week 0), and after the intervention phase (week 13))

Answer: A